Welcome Guest user | Login via OpenAthens or your home institution
Titles
Future Medicine eBooks
Future Medicine Journals
Future Science eBooks
Future Science Journals
Resources
Register
For Authors
For Reviewers
For Librarians
For Advertisers
Submitting an article
Services
Alerts
Subscriptions/Pricing
Institutional Trials
Reprints
Supplements
Permission Requests
Press Releases/News
Help
Downloads/Links
Online Submission
2017 Catalogue
Library Recommendation
Future Science Group
 

Citation
January 2012 ,Vol. 7, No. 1, Pages 7-13 , DOI 10.2217/rme.11.112
(doi:10.2217/rme.11.112)

Commentary

Peak serum: implications of serum supply for cell therapy manufacturing

David A Brindley​‌*1,2,3,4, Natasha L Davie​‌1,2,4,5, Emily J Culme-Seymour​‌4,6, Chris Mason​‌1,4, David W Smith​‌7 & Jon A Rowley​‌7
* Author for correspondence

These authors contributed equally

Free first page


Full Text PDF (818 KB) PDF Plus (830 KB)

Cited by

, , , , , , , . (2016) Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and future. Stem Cell Research & Therapy 7:1.
Online publication date: 13-Jul-2016.
CrossRef
, , , , , , . (2016) The preservation of living cells with biocompatible microparticles. Nanotechnology 27:26, 265101.
Online publication date: 1-Jul-2016.
CrossRef
, , , , , , , , . (2016) Developing an automated robotic factory for novel stem cell therapy production. Regenerative Medicine 11:4, 351-354.
Online publication date: 11-May-2016.
Citation | Full Text | PDF (1075 KB) | PDF Plus (1088 KB)  | Reprints & Permissions
, , , . (2016) Platelet-rich plasma therapy: another appealing technology for regenerative medicine?. Regenerative Medicine 11:4, 355-357.
Online publication date: 18-May-2016.
Citation | Full Text | PDF (735 KB) | PDF Plus (751 KB)  | Reprints & Permissions
, , , , . (2016) Phenotypic Modulation and Neuroprotective Effects of Olfactory Ensheathing Cells: a Promising Tool for Cell Therapy. Stem Cell Reviews and Reports 12:2, 224-234.
Online publication date: 1-Apr-2016.
CrossRef
, , , , , , , . (2016) Revisiting MSC expansion from critical quality attributes to critical culture process parameters. Process Biochemistry.
Online publication date: 1-Apr-2016.
CrossRef
, , , , , , . (2016) Characterization of human mesenchymal stem cells from multiple donors and the implications for large scale bioprocess development. Biochemical Engineering Journal 108, 14-23.
Online publication date: 1-Apr-2016.
CrossRef
, , , , , , , , , . (2016) Bioprocessing of human mesenchymal stem/stromal cells for therapeutic use: Current technologies and challenges. Biochemical Engineering Journal 108, 3-13.
Online publication date: 1-Apr-2016.
CrossRef
, , , , , , , . (2016) Scalability and process transfer of mesenchymal stromal cell production from monolayer to microcarrier culture using human platelet lysate. Cytotherapy 18:4, 523-535.
Online publication date: 1-Apr-2016.
CrossRef
, , , . 2016. Cell therapy manufacturing: identifying and meeting demand. Stem Cells in Regenerative Medicine, 49-68.
CrossRef
, . (2016) Equine platelet lysate as an alternative to fetal bovine serum in equine mesenchymal stromal cell culture - too much of a good thing?. Equine Veterinary Journal 48:10.1111/evj.2016.48.issue-2, 261-264.
Online publication date: 1-Mar-2016.
CrossRef
, , , , . 2016. Scalable Manufacture for Cell Therapy Needs. Bioreactors, 113-146.
CrossRef
, , , , , , , , , . (2016) Integrated culture platform based on a human platelet lysate supplement for the isolation and scalable manufacturing of umbilical cord matrix-derived mesenchymal stem/stromal cells. Journal of Tissue Engineering and Regenerative Medicine.
Online publication date: 22-Jul-2016.
CrossRef
, , , . 2016. Storage and Delivery of Stem Cells for Cellular Therapies. Stem Cell Manufacturing, 233-264.
CrossRef
, , . 2016. Expansion and Characterization Considerations for the Manufacturing of Stem Cells. Stem Cell Manufacturing, 215-231.
CrossRef
, , , , , , , . (2015) Serum-free process development: improving the yield and consistency of human mesenchymal stromal cell production. Cytotherapy 17:11, 1524-1535.
Online publication date: 1-Nov-2015.
CrossRef
, , , , , , , . (2015) Human microvascular endothelial cells displaying reduced angiogenesis and increased uptake of lipids during in vitro culture. Clinical Hemorheology and Microcirculation 61, 367-383.
Online publication date: 5-Oct-2015.
CrossRef
, , , , , , , . (2015) Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum-free microcarrier process. Biotechnology and Bioengineering 112:10.1002/bit.v112.8, 1696-1707.
Online publication date: 1-Aug-2015.
CrossRef
, , , , , , . (2015) Towards a commercial process for the manufacture of genetically modified T cells for therapy. Cancer Gene Therapy 22, 72-78.
Online publication date: 1-Mar-2015.
CrossRef
, , , , , , , . (2015) Ex vivo expansion of human T cells for adoptive immunotherapy using the novel Xeno-free CTS Immune Cell Serum Replacement. Clinical & Translational Immunology 4, e31.
Online publication date: 16-Jan-2015.
CrossRef
, . (2015) Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies. Immunological Reviews 263:10.1111/imr.2014.263.issue-1, 68-89.
Online publication date: 1-Jan-2015.
CrossRef
, , , . 2014. Pillars of Regenerative Medicine: Therapeutic Human Cells and Their Manufacture. Industrial Scale Suspension Culture of Living Cells, 464-502.
CrossRef
, , , . (2014) Antibody-modified T cells: CARs take the front seat for hematologic malignancies. Blood 123, 2625-2635.
Online publication date: 24-Apr-2014.
CrossRef
, , , , . (2014) Albumin-coated structural lyophilized bone allografts: a clinical report of 10 cases. Cell and Tissue Banking 15, 89-97.
Online publication date: 1-Mar-2014.
CrossRef
, , . (2014) Adult adherent stromal cells in the management of graft-versus-host disease. Expert Opinion on Biological Therapy 14, 231-246.
Online publication date: 1-Feb-2014.
CrossRef
, . (2013) Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology. Immunity 39, 49-60.
Online publication date: 1-Jul-2013.
CrossRef
, , . (2013) Substrates and supplements for hESCs: a critical review. Journal of Assisted Reproduction and Genetics 30, 315-323.
Online publication date: 1-Mar-2013.
CrossRef
, , . (2013) Scale-up of human mesenchymal stem cell culture: current technologies and future challenges. Current Opinion in Chemical Engineering 2, 8-16.
Online publication date: 1-Feb-2013.
CrossRef
, . Cell therapy commercialisation. Progenitor and stem cell technologies and therapies, 169-205.
CrossRef

Users who read this article also read:


 Cell therapy industry: billion dollar global business with unlimited potential
, , ,
Regenerative Medicine, Vol. 6, No. 3, Pages 265-272.
Citation | Full Text | PDF (1993 KB) | PDF Plus (2016 KB) | Add to Favorites | Related 

 The translation of cell-based therapies: clinical landscape and manufacturing challenges
, , , , ,
Regenerative Medicine, Vol. 10, No. 1, Pages 49-64.
Summary | Full Text | PDF (985 KB) | PDF Plus (1054 KB) | Add to Favorites | Related 

Developing assays to address identity, potency, purity and safety: cell characterization in cell therapy process development
, , ,
Regenerative Medicine, Vol. 7, No. 1, Pages 85-100.
Summary | Full Text | PDF (1017 KB) | PDF Plus (1055 KB) | Add to Favorites | Related 

 A decade of cell therapy clinical trials (2000–2010)
, , , ,
Regenerative Medicine, Vol. 7, No. 4, Pages 455-462.
Citation | Full Text | PDF (2018 KB) | PDF Plus (2033 KB) | Add to Favorites | Related 
 

Prev. Article | Next Article
View/Print PDF (818 KB)
View PDF Plus (830 KB)
Add to favorites
Email to a friend
TOC Alert | Citation Alert What is RSS?


Quick Search
for
Authors:
David A Brindley
Natasha L Davie
Emily J Culme-Seymour
Chris Mason
David W Smith
Jon A Rowley
Keywords:
biomanufacturing
bioprocessing
cell therapy
commercialization
fetal bovine serum
manufacturing
process optimization
serum